{
  "url": "https://openlegislation.uk/medical-devices-and-blood-safety-and-quality-fees-amendment-regulations-2023/regulation-4",
  "json_url": "https://openlegislation.uk/medical-devices-and-blood-safety-and-quality-fees-amendment-regulations-2023/regulation-4.json",
  "legislation": "uksi/2023/377",
  "legislation_title": "The Medical Devices and Blood Safety and Quality (Fees Amendment) Regulations 2023",
  "legislation_url": "https://openlegislation.uk/medical-devices-and-blood-safety-and-quality-fees-amendment-regulations-2023",
  "path": "regulation/4",
  "kind": "regulation",
  "number": "4",
  "heading": "Amendment of regulation 2 in relation to England, Scotland and Wales (interpretation)",
  "text": "In regulation 2(1), insert at the appropriate place—\n““statistical review” means a review of the statistical sections of the written notice which a manufacturer or their UK responsible person submits to the Secretary of State pursuant to regulation 16(1) or 29(1) in respect of an intended clinical investigation of a relevant device;”.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "footnote",
      "label": "f1",
      "text": "Amended by S.I. 2003/1697, 2007/400, 2008/2936, 2012/1426, 2013/2327, 2019/791, 2021/873, 2021/910 and section 41(4) of the Medicines and Medical Devices Act 2021 (c. 3)."
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2023/377/regulation/4",
    "retrieved_at": "2026-10-28T21:47:16.303858+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}